+13.1%
GSK vs SWK
+87.6%
-74.5%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | SWK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.0% | +13.1% | -8.1% | +2.3% |
| 7D | +4.9% | +17.9% | -12.9% | +1.4% |
| 30D | +9.9% | +31.9% | -22.1% | +4.0% |
| 3M | +0.2% | +16.6% | -16.4% | -3.0% |
| 6M | +2.3% | +61.1% | -58.8% | -8.1% |
| YTD | +7.1% | +64.2% | -57.1% | -5.2% |
| 1Y | +13.1% | +85.2% | -72.1% | -2.0% |
| All | +13.1% | +87.6% | -74.5% | -2.0% |
Cumulative growth
Daily Returns
Daily percentage return beside SWK.
Daily Out/Under-Performance
Portfolio return minus SWK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SWK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded SWK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling